Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Size, Share, Revenue, Trends, and Drivers For 2024-2033

The Business Research Company’s Ribose-Nucleic Acid (RNA)-Based Therapeutics Global Market Report 2024 – Market Size, Trends, And Global Forecast 2024-2033

LONDON, GREATER LONDON, UNITED KINGDOM, September 19, 2024 /EINPresswire.com/ — The ribose-nucleic acid (RNA)-based therapeutics market has experienced robust growth in recent years, expanding from $14.54 billion in 2023 to $15.79 billion in 2024 at a compound annual growth rate (CAGR) of 8.6%. The growth in the historic period can be attributed to investment and funding growth, the discovery of RNA interference (RNAi), clinical successes of antisense oligonucleotides (ASOs), regulatory support and frameworks, and collaborations, and partnerships.

What Is The Estimated Market Size Of The Global Ribose-Nucleic Acid (RNA)-Based Therapeutics Market And Its Annual Growth Rate?
The ribose-nucleic acid (RNA)-based therapeutics market is projected to continue its strong growth, reaching $22.30 billion in 2028 at a compound annual growth rate (CAGR) of 9.0%. The growth in the forecast period can be attributed to the expansion of indications, rising market demand and adoption, regulatory support, integration of AI and machine learning, and emerging applications in rare diseases.

Explore Comprehensive Insights Into The Global Ribose-Nucleic Acid (RNA)-Based Therapeutics Market With A Detailed Sample Report:

Growth Driver Of The Ribose-Nucleic Acid (RNA)-Based Therapeutics Market
The increasing prevalence of cancer is expected to propel the growth of the ribose-nucleic acid (RNA)-based therapeutics market going forward. Cancer refers to a condition where abnormal cells grow and spread uncontrollably, potentially leading to death if untreated. The prevalence of cancer is due to an aging population, lifestyle changes, greater exposure to risks, and better detection methods. RNA-based therapeutics offer a promising avenue for cancer treatment by directly targeting the genetic and molecular mechanisms of cancer.

Make Your Report Purchase Here And Explore The Whole Industry’s Data As Well:

Who Are The Leading Competitors In The Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Share?
Key players in the market include F. Hoffmann-La Roche AG, Eli Lilly and Company, Novo Nordisk A/S, Regeneron Pharmaceuticals, Biogen Inc., Houston Methodist Hospital, BioNTech, University of Oxford, Alnylam Pharmaceuticals, Sarepta Therapeutics, Flagship Pioneering, Ionis Pharmaceuticals, Akcea Therapeutics Inc, Arrowhead Pharmaceuticals, Dicerna Pharmaceuticals, Wave Life Sciences, Pharmaceutical Technology, Quark Pharmaceuticals, Tekmira Pharmaceuticals, ReCode Therapeutics, Arbutus Biopharma Corporation, Benitec Biopharma Inc., Olix Pharmaceuticals, Alltrna Inc., Orbital Therapeutics.

What Are The Dominant Trends In Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Growth?
Major companies operating in the ribose nucleic acid (RNA)-based therapeutics market are focused on developing innovative medication solutions, such as messenger RNA (mRNA)-based booster vaccines, to enhance the effectiveness of immunization, address emerging viral variants, and improve the overall durability of vaccine-induced immunity. An mRNA-based booster vaccine uses messenger RNA to prompt cells to create a protein that enhances the body’s immune response against a particular pathogen.

How Is The Global Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Segmented?
1) By Type: RNA Interference (RNAi), RNA Antisense
2) By Technology: Enabling Technology, Enabled Technology
3) By Therapeutic Area: Oncology, Genetic Disorder, Ophthalmology, Hematological Disorders, Acute Hepatic Porphyria (AHP), Other Therapeutic Areas
4) By End User: Research Institutes, Hospitals And Clinics

Geographical Insights: North America Leading The Ribose-Nucleic Acid (RNA)-Based Therapeutics Market
North America was the largest region in the market in 2023. The regions covered in the report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Definition
The ribose-nucleic acid (RNA)-based therapeutics refer to a class of medical treatments that utilize ribose-nucleic acid (RNA) molecules to influence cellular processes, typically by targeting specific genetic sequences. These therapies are designed to treat various conditions, including genetic disorders, cancers, and infectious diseases, by modulating gene expression, protein production, or cellular signaling pathways.

Ribose-Nucleic Acid (RNA)-Based Therapeutics Global Market Report 2024 from TBRC covers the following information:
• Market size data for the forecast period: Historical and Future
• Macroeconomic factors affecting the market in the short and long run
• Analysis of the macro and micro economic factors that have affected the market in the past five years
• Market analysis by region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
• Market analysis by countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

An overview of the global ribose-nucleic acid (RNA)-based therapeutics market report covering trends, opportunities, strategies, and more
The Ribose-Nucleic Acid (RNA)-Based Therapeutics Global Market Report 2024 by The Business Research Company is the most comprehensive report that provides insights on ribose-nucleic acid (RNA)-based therapeutics market size, ribose-nucleic acid (RNA)-based therapeutics market drivers and trends, ribose-nucleic acid (RNA)-based therapeutics market major players and ribose-nucleic acid (RNA)-based therapeutics market growth across geographies. This report helps you gain in-depth insights into opportunities and strategies. Companies can leverage the data in the report and tap into segments with the highest growth potential.

Browse Through More Similar Reports By The Business Research Company:

Nucleic Acid Extraction Instruments And Reagents Global Market Report 2024

Automated Nucleic Acid Extraction Devices Global Market Report 2024

Isothermal Nucleic Acid Amplification Technology (INAAT) Global Market Report 2024

What Does the Business Research Company Do?
The Business Research Company publishes over 15,000 reports across 27 industries and 60+ geographies. Our research is powered by 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. We provide continuous and custom research services, offering a range of specialized packages tailored to your needs, including Market Entry Research Package, Competitor Tracking Package, Supplier & Distributor Package, and much more.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
[email protected]
Visit us on social media:
Facebook
X
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.